inno-train
inno-train Diagnostik GmbH is a German in-vitro diagnostics manufacturer founded in 1998, supplying molecular diagnostic kits, instruments, and software for HLA, HPA, RBC, and KIR typing to clinical laboratories, transplant centers, and blood banks in over 50 countries.
- Company typePrivate
- Founded1998
- HeadquartersKronberg, Germany
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What inno-train does
inno-train Diagnostik GmbH is a privately held German in-vitro diagnostics (IVD) manufacturer founded in 1998 and headquartered in Kronberg im Taunus, with a North American division in Clinton, New York, established in 2018. The company develops and produces molecular diagnostic kits, automation instruments, and analysis software for transfusion and transplantation medicine, specifically HLA, HPA, RBC (blood group), and KIR typing used by clinical laboratories, transplant centers, blood banks, and immunohematology reference labs.
Its core technology stack spans four diagnostic modalities: serology (HLA-Ready Plate and RBC Serology), SSP-PCR (Ready Gene product lines for HLA, HPA, RBC, and KIR), TaqMan-based real-time PCR (FluoGene systems for HLA, HPA, and RBC including the RBC-FluoGene Q liquid mix line), and Illumina-based next-generation sequencing (HLA-SuBiTo NGStype and RBC-NGStype). These are supported by proprietary automated instruments (BEXS 12 for DNA/RNA extraction, FluoQube and FluoQube384 real-time cyclers) and dedicated software (FluoGene Software, NGStype Software, Ready Gene Online) with LIMS export. The company also distributes DaraEx (anti-CD38 neutralizing agent) and recombinant blood group antigens under a worldwide agreement with imusyn.
Revenue is generated through one-time sales of IVD kits (HLA, HPA, RBC, KIR consumables across SSP-PCR, real-time PCR, and NGS), instrument sales (FluoQube line, BEXS 12), software licensing, and paid training/support services. Distribution combines a direct sales force in Germany and North America with a distributor network spanning 50+ countries, supported by active participation in EFI, ISBT, ASHI, and AABB conferences and the company's own annual Molecular Blood Group Forum in Frankfurt. The company has been ISO 13485-certified since 2003 (audited annually by TÜV SÜD) and, in February 2026, achieved IVDR 2017/746 certification for its HLA-Ready Gene and HLA-FluoGene product lines plus the HLA part of FluoGene Software. It receives non-dilutive EU ERDF co-funding for the ongoing RBC-NGStype BloodSeq NGS kit development project.
inno-train firmographics
Firmographics- Name
- inno-train
- Legal name
- inno-train Diagnostik GmbH
- Website
- https://inno-train.de
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- inno-train Diagnostik GmbH is a German in-vitro diagnostics manufacturer founded in 1998, supplying molecular diagnostic kits, instruments, and software for HLA, HPA, RBC, and KIR typing to clinical laboratories, transplant centers, and blood banks in over 50 countries.
- Ownership category
- akta.pro rank
inno-train industry classification
Industry- Product category
- Molecular Diagnostics for Transfusion Medicine
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Medical Equipment and Supplies Manufacturing (3391), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)
- akta.pro secondary industries
- Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL), Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH), Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO), Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF), Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)
Keywords
Where inno-train is headquartered
LocationHeadquarters
- HQ city
- Kronberg
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
inno-train business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- IVD Diagnostic Kits: Sale of molecular diagnostic kits for HLA typing, blood group typing (RBC), and human platelet antigens (HPA) including SSP-PCR, Real-Time PCR, and NGS-based products. Products sold as ready-to-use kits with proprietary primer/probe mixes.
- Laboratory Instruments: Sale of real-time PCR instruments (FluoQube, FluoQube384), DNA extraction systems (BEXS 12), and automation equipment.
- Software Licenses: Licensing of FluoGene Software, NGStype Software, and Ready Gene Online for data analysis and result interpretation.
- Training and Support Services: In-person and online training workshops, webinars, and technical support services for customers and distributors.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Standard B2B pricing with volume considerations |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
inno-train product offering
Product offeringCore offering
inno-train Diagnostik GmbH manufactures and supplies in-vitro diagnostic kits, automation instruments, and analysis software for transfusion and transplantation medicine. Its product portfolio covers HLA, HPA, RBC, and KIR typing across four methodologies—serology, SSP-PCR, Real-Time PCR (TaqMan-based SSP), and Next Generation Sequencing—supported by proprietary instruments (FluoQube, FluoQube384, BEXS 12), dedicated software (FluoGene, NGStype, Ready Gene Online), and distributed products (DaraEx, recombinant blood group antigens). The complete integrated workflow runs from automated DNA extraction through PCR amplification to software-based result interpretation.
Product overview
inno-train Diagnostik GmbH is a German in-vitro diagnostics company founded in 1998, offering a comprehensive portfolio for transfusion medicine and immunohematology. The product ecosystem consists of four core testing methodologies: Serology (HLA-Ready Plate, RBC Serology), SSP-PCR (HLA-Ready Gene, HPA-Ready Gene, RBC-Ready Gene, KIR Ready Gene), Real-Time PCR (HLA-FluoGene, HPA-FluoGeneNX, RBC-FluoGene, RBC-FluoGene Q), and Next Generation Sequencing (HLA-SuBiTo NGStype, RBC-NGStype). The complete workflow is supported by automation instruments (BEXS 12 for DNA extraction, FluoQube/FluoQube384 for real-time PCR, FluoVista for endpoint fluorescence reading), analysis software (FluoGene Software, NGStype Software, Ready Gene Online), and distributed products (DaraEx, Recombinant Blood Group Antigens from imusyn). The company holds ISO 13485:2016 certification, IVDR 2017/746 certification for HLA products, and serves customers in over 50 countries with headquarters in Kronberg, Germany and a North American division in Clinton, New York.
Differentiator
Problem solved
Functional benefit
Brands
- FluoGene: Automation system for molecular diagnostics combining DNA extraction, automated testing, real-time instruments, and software for result analysis
- Ready Gene
- FluoQube
- FluoQube384
- BEXS 12
- NGStype
- DaraEx
- Recombinant Blood Group Antigens (rBGA)
- RBC-FluoGene Q
- RBC-NGStype
Products and services
- HLA-Ready Gene
- HLA-SuBiTo NGStype
- HLA-Ready Plate
- HLA-FluoGene
- HPA-Ready Gene
- HPA-FluoGeneNX
- RBC-Ready Gene
- RBC-NGStype
- RBC-FluoGene
- RBC-FluoGene Q
- KIR Ready Gene
- FluoQube
- FluoQube384
- BEXS 12
- FluoGene Software
- NGStype Software
- Ready Gene Online
- DaraEx
- Recombinant Blood Group Antigens (rBGA)
Quantifiable outcome
- DNA extraction purity A260/A280 ~ 1.8 with 5-10 μg yield from 250 μL blood
- +4 more outcomes
Companies that use inno-train
Customer profileSegments3 records
Ideal customer profiles3 records
inno-train technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
Feature9 records
inno-train partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- imusyncoreimusyn is a German biotechnology company whose serological products (DaraEx and recombinant blood group antigens) inno-train distributes worldwide. DaraEx neutralizes therapeutic anti-CD38 antibodies interfering with pretransfusion testing. inno-train acquired sales rights for these products and distributes them globally since March 1st.
- Illuminacoreinno-train's NGS products (HLA-NGStype, RBC-NGStype) are designed for Illumina sequencing platforms. The RBC-NGStype CORE kit runs on Illumina MiSeq Nano (0.3 Gb) Flow Cell and works with all Illumina platforms.
- Immunohematology Reference Laboratories and Opinion Leaderscoreinno-train collaborates with immunohematology reference laboratories and opinion leaders for product development. Products developed in close collaboration with experts including Prof. Dr. Christoph Gassner.
- Prof. Dr. Christoph GassnercoreProduct developed in collaboration with Prof. Dr. Christoph Gassner (Private University in the Principality of Liechtenstein). Expert contributor to Molecular Blood Group Forum and product validation.
Scale indicators7 records
Recent moves9 records
Expansion highlights6 records
inno-train competitors and assessment
Company assessmentDirect peers
- Immucor: Immucor is a direct competitor in transfusion and transplant diagnostics, manufacturing serology, SSP-PCR, and molecular blood bank reagents — the same workflow categories in which inno-train competes for hospital blood bank and immunohematology lab accounts.
- Bio-Rad Laboratories: Bio-Rad's ID-Card LISS/Coombs gel cards are explicitly listed as compatible with inno-train's recombinant blood group antigens, and Bio-Rad is a major vendor of HLA and blood bank reagents; it is a direct competitor for serology and ancillary transfusion medicine consumables worldwide.
- Grifols: Grifols' DG Gel Coombs gel cards are listed as compatible with inno-train's recombinant blood group antigens; Grifols is one of the largest global suppliers of blood bank serology and immunohematology products, directly overlapping with inno-train's transfusion diagnostics portfolio.
- Thermo Fisher Scientific (One Lambda): One Lambda, part of Thermo Fisher, is a global leader in HLA typing kits and software for transplantation diagnostics, competing head-to-head with inno-train's HLA-Ready Gene, HLA-FluoGene, and HLA-SuBiTo NGStype product lines for transplant center business.
- GenDx: GenDx (now under Eurobio Scientific) is a specialist in NGS and Sanger-based HLA and KIR typing reagents and software, directly competing with inno-train's NGStype and HLA-SSP product lines for transplant immunogenetics laboratories.
- CareDx: CareDx focuses on transplant surveillance and HLA-based diagnostics for solid organ and stem cell transplant centers, overlapping with inno-train's transplantation diagnostics customer base and HLA typing offering.
Broad incumbents
- QIAGEN: QIAGEN is a broad molecular diagnostics and sample-preparation incumbent whose QIAcube and PCR reagents partially overlap with inno-train's BEXS 12 extraction system and SSP/qPCR kit offerings, although it is not focused exclusively on transfusion medicine.
- Hologic: Hologic is a diversified diagnostics incumbent whose Panther and molecular IVD platforms serve reference labs that also purchase HLA, RBC, and HPA reagents, making it a broad-incumbent alternative for some of inno-train's clinical lab customers.
- Becton, Dickinson and Company (BD): BD's Life Sciences and Diagnostic Systems segments include blood collection, molecular reagents, and flow cytometry used by blood banks and immunogenetics labs; BD Life Sciences competes broadly for the same lab budgets as inno-train, though it does not specialize in transfusion IVD kits.
Emerging players
- Cepheid (Danaher): Cepheid's GeneXpert molecular systems are deployed in hospital and reference labs that also buy immunohematology reagents; while not focused on blood group typing, the platform-level overlap in molecular IVD lab workflows makes Cepheid an adjacent competitive reference for inno-train's molecular IVD customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
inno-train social profiles
Digital presenceinno-train compliance and trust
Trust signalCompliance2 records
inno-train financial estimates
Financial estimateRevenue estimate
Valuation estimate
inno-train leadership team
Management profileNumber of profiles
Profiles7 records
inno-train funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
inno-train M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about inno-train
What does inno-train do?
inno-train Diagnostik GmbH manufactures and supplies in-vitro diagnostic kits, automation instruments, and analysis software for transfusion and transplantation medicine. Its product portfolio covers HLA, HPA, RBC, and KIR typing across four methodologies—serology, SSP-PCR, Real-Time PCR (TaqMan-based SSP), and Next Generation Sequencing—supported by proprietary instruments (FluoQube, FluoQube384, BEXS 12), dedicated software (FluoGene, NGStype, Ready Gene Online), and distributed products (DaraEx, recombinant blood group antigens). The complete integrated workflow runs from automated DNA extraction through PCR amplification to software-based result interpretation.
Is inno-train a public or private company?
inno-train is a private company. It is classified as management employee owned and is currently operating.
When was inno-train founded?
inno-train was founded in 1998. It employs 51 to 100 people.
Where is inno-train based?
inno-train is headquartered in Kronberg, Germany, in the Europe region.
How does inno-train make money?
Four revenue lines are on record. IVD Diagnostic Kits are the primary driver. The others are laboratory Instruments, software Licenses and training and Support Services.
Who are inno-train's main competitors?
Direct peers on record are Immucor, Bio-Rad Laboratories, Grifols, Thermo Fisher Scientific (One Lambda), GenDx and CareDx. Broad incumbents are QIAGEN, Hologic and Becton, Dickinson and Company (BD). Cepheid (Danaher) is listed as an emerging player.
Does inno-train have an API?
No public API is recorded for inno-train.
What industry is inno-train in?
inno-train's product category is Molecular Diagnostics for Transfusion Medicine. Its primary akta.pro industry code is HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD), with a secondary code of HLAAALAL, Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays). Its NAICS code is 325413 and its SIC code is 2835.